Gara Jalqabaatti › Kansarii Ovarii › California › Mountain View
Qorannoo klinikaalii Kansarii Ovarii Mountain View, CA keessatti
Qorannoo 19 Kansarii Ovarii f Mountain View fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Namoota walitti qabaa jiraSadarkaa 2/3
- Stanford Cancer Institute Palo Alto, Palo Alto · Miili 5 fagaatti
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Namoota walitti qabaa jiraSadarkaa 2
- Stanford Cancer Institute Palo Alto, Palo Alto · Miili 5 fagaatti
- VA Palo Alto Health Care System, Palo Alto · Miili 5 fagaatti
A Study of PHST001 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University School of Medicine, Palo Alto · Miili 5 fagaatti
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- Stanford University, Palo Alto · Miili 5 fagaatti
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Stanford Women's Cancer Center, Palo Alto · Miili 5 fagaatti
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University Medical Center, Stanford · Miili 5 fagaatti
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Stanford University, Palo Alto · Miili 5 fagaatti
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Stanford, Palo Alto · Miili 5 fagaatti
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · Miili 5 fagaatti
- fi 1 dabalataa
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Namoota walitti qabaa jiraSadarkaa 2
- 150, Palo Alto · Miili 5 fagaatti
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Namoota walitti qabaa jiraSadarkaa 3
- Palo Alto Medical Foundation, Palo Alto · Miili 5 fagaatti
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford University, Stanford · Miili 5 fagaatti
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Women's Cancer Center, Palo Alto · Miili 5 fagaatti
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Namoota walitti qabaa jiraQorannoo ilaalaa
- Stanford University School of Medicine, Stanford · Miili 5 fagaatti
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Stanford Ambulatory Surgery Center Lane Operating Room, Palo Alto · Miili 5 fagaatti
- Stanford Women's Cancer Center, Palo Alto · Miili 5 fagaatti
- Stanford Hospital, Palo Alto · Miili 5 fagaatti
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Namoota walitti qabaa jiraSadarkaa 2
- Stanford Cancer Center, Palo Alto · Miili 5 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Stanford · Miili 5 fagaatti
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Philadelphia, PAQorannoo 44
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
Qorannoo biroo Mountain View keessatti
- Saree (Gosoota Hunda)Qorannoo 40
- Saree OljooQorannoo 26
- Kansara MetastatikiiQorannoo 25
- Kansara Qara'a Non-Small CellQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 19
- Dhibee Spektiraamii AutisimiiQorannoo 17
- Dhibee QaraQorannoo 17
- Kansarii ProstateQorannoo 15
- Cufama OnneeQorannoo 15
- AutismQorannoo 13
- Leukemia Lymphoblasticii HamaaQorannoo 13
- Kansarii ColorectalQorannoo 13
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.